In the news
Dr. Svaren (Comparative Biosciences, Waisman Center)
Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves (June 2020).
Dr. Pike (Biochemistry)
Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression (Febuary 2020).
Dr. Bresnick (TALENs, Cell & Regenerative Biology)
GATA Factor-Regulated Samd14 Enhancer Confers Red Blood Cell Regeneration and Survival in Severe Anemia (August 2017).
Genome Editing and Animal Models Core (GEAM), formerly known as the Translational Genomic Facility and Transgenic Animal Facility, was reorganized in 2017. The Transgenic Animal Facility was established in 1988 and has a long history of providing UW Madison researchers access to the latest technology for generating transgenic and gene targeted animals at a reasonable cost. They have been nationally recognized for their work in manipulating rat embryos and have been very successful in incorporating CRISPR/Cas9 technology into their program.